The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II single arm prospective study of high dose testosterone in combination with carboplatin chemotherapy in late line metastatic castrate-resistant prostate cancer (HIGH-TeCH study).
 
Megan Crumbaker
Honoraria - Bayer; Merck
Consulting or Advisory Role - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - MSD Oncology
 
Samantha Shekar
No Relationships to Disclose
 
Mitchell Lawrence
Research Funding - AstraZeneca
Other Relationship - Pfizer
 
Leonard Goldstein
Employment - Datapharm Australia Pty Ltd (I)
Patents, Royalties, Other Intellectual Property - Genentech
 
Andrew Yam
No Relationships to Disclose
 
Teesha Downton
No Relationships to Disclose
 
Stephen Begbie
Consulting or Advisory Role - Astellas Pharma; Bayer; Merck Serono; MSD Oncology; Pfizer
Research Funding - Astellas Medivation (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck Serono (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Roche (Inst)
 
Rob Zielinski
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; MSD; Pfizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca; Bristol-Myers Squibb
 
William Fox
No Relationships to Disclose
 
Nicole Araiza
No Relationships to Disclose
 
Jacob Yousif
No Relationships to Disclose
 
Lalith Ratnayake
No Relationships to Disclose
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Samuel Denmeade
Research Funding - Astellas Pharma (Inst); Bayer
Patents, Royalties, Other Intellectual Property - Patent licensed to Pfizer receive patent maintenance fees
 
Anthony Joshua
Stock and Other Ownership Interests - Pricilium Therapeutics
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Grey Wolf Therapeutics (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Mayne Pharma (Inst); Medison (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Starpharma (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Genentech (Inst); Immunocore (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Myeloid Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods